Updates in the Management of Relapsing Multiple Sclerosis

home / peer-exchange / updates-in-the-management-of-relapsing-multiple-sclerosis

Fred Lublin, MD; Patricia K. Coyle, MD; Mark Freedman, MD; and Scott D. Newsome, DO, discuss a number of topics pertaining to the diagnosis of multiple sclerosis, including a focus on fatigue and its impact on quality of life.

2017 Changes to the McDonald Criteria: Diagnosing Multiple Sclerosis

EP. 1: 2017 Changes to the McDonald Criteria: Diagnosing Multiple Sclerosis

Fred Lublin, MD;Patricia K. Coyle, MD;Scott Newsome, DO, MSCS, FAAN;Mark Freedman, MD, MSc, HBSc, CSPQ, FANA, FAAN, FRCPC
December 16th 2020
Video
Use of MRI in Diagnosing Multiple Sclerosis

EP. 2: Use of MRI in Diagnosing Multiple Sclerosis

Fred Lublin, MD;Patricia K. Coyle, MD;Scott Newsome, DO, MSCS, FAAN;Mark Freedman, MD, MSc, HBSc, CSPQ, FANA, FAAN, FRCPC
December 23rd 2020
Video
Misdiagnosis of Multiple Sclerosis

EP. 3: Misdiagnosis of Multiple Sclerosis

Fred Lublin, MD;Patricia K. Coyle, MD;Scott Newsome, DO, MSCS, FAAN;Mark Freedman, MD, MSc, HBSc, CSPQ, FANA, FAAN, FRCPC
December 25th 2020
Video
Cerebrospinal Fluid in Diagnosing Multiple Sclerosis

EP. 4: Cerebrospinal Fluid in Diagnosing Multiple Sclerosis

Fred Lublin, MD;Patricia K. Coyle, MD;Scott Newsome, DO, MSCS, FAAN;Mark Freedman, MD, MSc, HBSc, CSPQ, FANA, FAAN, FRCPC
December 28th 2020
Video
Challenges in Optimally Treating Multiple Sclerosis

EP. 5: Challenges in Optimally Treating Multiple Sclerosis

Fred Lublin, MD;Patricia K. Coyle, MD;Scott Newsome, DO, MSCS, FAAN;Mark Freedman, MD, MSc, HBSc, CSPQ, FANA, FAAN, FRCPC
December 31st 2020
Video
QoL Issues in the Management of Multiple Sclerosis

EP. 6: QoL Issues in the Management of Multiple Sclerosis

Fred Lublin, MD;Patricia K. Coyle, MD;Scott Newsome, DO, MSCS, FAAN;Mark Freedman, MD, MSc, HBSc, CSPQ, FANA, FAAN, FRCPC
January 1st 2021
Video
Multiple Sclerosis Fatigue

EP. 7: Multiple Sclerosis Fatigue

Fred Lublin, MD;Patricia K. Coyle, MD;Scott Newsome, DO, MSCS, FAAN;Mark Freedman, MD, MSc, HBSc, CSPQ, FANA, FAAN, FRCPC
January 4th 2021
Video
TRIUMPHANT-MS Trial: Fatigue in MS

EP. 8: TRIUMPHANT-MS Trial: Fatigue in MS

Fred Lublin, MD;Patricia K. Coyle, MD;Scott Newsome, DO, MSCS, FAAN;Mark Freedman, MD, MSc, HBSc, CSPQ, FANA, FAAN, FRCPC
January 5th 2021
Video
OPTIMUM Phase 3 Trial: Secondary End Point Effect on Fatigue

EP. 9: OPTIMUM Phase 3 Trial: Secondary End Point Effect on Fatigue

Fred Lublin, MD;Patricia K. Coyle, MD;Scott Newsome, DO, MSCS, FAAN;Mark Freedman, MD, MSc, HBSc, CSPQ, FANA, FAAN, FRCPC
January 12th 2021
Video
Strategies for Choosing Initial Therapy in MS

EP. 10: Strategies for Choosing Initial Therapy in MS

Fred Lublin, MD;Patricia K. Coyle, MD;Scott Newsome, DO, MSCS, FAAN;Mark Freedman, MD, MSc, HBSc, CSPQ, FANA, FAAN, FRCPC
January 15th 2021
Video
Anti-CD20 Monoclonal Antibodies for Treatment of RMS

EP. 11: Anti-CD20 Monoclonal Antibodies for Treatment of RMS

Fred Lublin, MD;Patricia K. Coyle, MD;Scott Newsome, DO, MSCS, FAAN;Mark Freedman, MD, MSc, HBSc, CSPQ, FANA, FAAN, FRCPC
January 18th 2021
Video
Cladribine for Treatment of RMS

EP. 12: Cladribine for Treatment of RMS

Fred Lublin, MD;Patricia K. Coyle, MD;Scott Newsome, DO, MSCS, FAAN;Mark Freedman, MD, MSc, HBSc, CSPQ, FANA, FAAN, FRCPC
January 20th 2021
Video
S1P Receptor Modulators for Treatment of RMS

EP. 13: S1P Receptor Modulators for Treatment of RMS

Fred Lublin, MD;Patricia K. Coyle, MD;Scott Newsome, DO, MSCS, FAAN;Mark Freedman, MD, MSc, HBSc, CSPQ, FANA, FAAN, FRCPC
January 21st 2021
Video
Fumarates for Treatment of RMS

EP. 14: Fumarates for Treatment of RMS

Fred Lublin, MD;Patricia K. Coyle, MD;Scott Newsome, DO, MSCS, FAAN;Mark Freedman, MD, MSc, HBSc, CSPQ, FANA, FAAN, FRCPC
January 26th 2021
Video
The Future of Managing Multiple Sclerosis

EP. 15: The Future of Managing Multiple Sclerosis

Fred Lublin, MD;Patricia K. Coyle, MD;Scott Newsome, DO, MSCS, FAAN;Mark Freedman, MD, MSc, HBSc, CSPQ, FANA, FAAN, FRCPC
February 2nd 2021
Video
© 2024 MJH Life Sciences

All rights reserved.